Visby Medical vs Cradle
Side-by-side comparison of AI visibility scores, market position, and capabilities
Visby Medical makes single-use handheld PCR diagnostic devices for point-of-care testing; received FDA EUA for COVID-19, flu A/B, and RSV tests; raised $250M+ total; partnered with Pfizer for commercialization;
About
Visby Medical is a San Jose, California-based medical diagnostics company that has developed a novel point-of-care PCR testing platform. Unlike conventional PCR testing, which requires large laboratory instruments and trained technicians, Visby's devices are single-use, handheld, and self-contained — delivering lab-accurate polymerase chain reaction results in under 30 minutes without any external reader or instrument. The disposable form factor allows testing at the point of care in clinics, pharmacies, urgent care centers, and even at home, eliminating the logistical overhead of sending samples to reference laboratories.
AI protein design platform combining language models with lab automation; active learning cycles for enzyme, antibody, and therapeutic protein engineering optimization.
About
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, activity, and manufacturability. Founded in 2021 and headquartered in Amsterdam with teams in San Francisco, Cradle raised approximately $24 million and targets biopharmaceutical, agricultural, and industrial biotechnology companies that need to engineer proteins with specific functional properties.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.